News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
23-Mar-2005 - Adult stem cell biotechnology and immunotherapy company, CyGenics, Ltd. announced that it has been granted a patent in China for its immune T cell production technology. This patent adds to the company's extensive worldwide intellectual property. It also protects one of the company's leading ...
23-Mar-2005 - Biovitrum announces that the company has agreed to acquire Cambridge Biotechnology Ltd ("CBT"), a Cambridge UK based private drug discovery company. Through this move, Biovitrum is developing its therapeutic area base, advancing and balancing the medical and commercial potential of the product ...
23-Mar-2005 - The Global Alliance for TB Drug Development (TB Alliance) and GlaxoSmithKline announced they will pursue a joint drug discovery program to improve the treatment of tuberculosis (TB). The program substantially enhances the worldwide TB drug pipeline by adding several novel classes of compounds ...
22-Mar-2005 - The approval of Monsanto's Bollgard cotton by Brazil's regulatory body, the National Commission for Biosafety (CTNBio) was an important step in the regulatory process for this product, said Jerry Glover, Vice-President External Affairs, Monsanto Company. "This is a positive step forward. ...
22-Mar-2005 - Nanotechnology may be in its infancy, but biologists may soon use it to watch the inner workings of a living cell like never before. Scientists at the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) and Lawrence Livermore National Laboratory have developed a way ...
22-Mar-2005 - Pall Corporation presented an overview of the latest research on its prion reduction technology as a new risk reduction measure to help prevent transfusion transmission of infectious prions that can cause vCJD. The Company expects to launch the new filter commercially in Europe this ...
22-Mar-2005 - TorreyPines Therapeutics, Inc. and Eisai Co., Ltd. announced the signing of a research agreement involving Alzheimer's disease drug discovery. The goal of the research performed by TorreyPines Therapeutics is to discover novel Alzheimer's disease modifying agents based on the study of the ...
22-Mar-2005 - Novartis Pharma AG and Schering AG announced that the analysis of progression free survival (PFS) as assessed by central radiology review in the CONFIRM 1 trial with the investigational drug PTK/ZK did not achieve statistical significance. However, a separate pre-planned analysis of ...
21-Mar-2005 - Sosei Co. Ltd. announced the appointment of Dr. David Chiswell as Non-Executive Chairman. David Chiswell was a founder and, from 1996 to 2002, the CEO of Cambridge Antibody Technology (CAT). Currently David is Chairman of the UK's BioIndustry Association (BIA). In addition, he is Chairman of ...
21-Mar-2005 - Enzon Pharmaceuticals, Inc. announced that it has entered into an agreement with INEX Pharmaceuticals Corporation to terminate the companies' partnership for the development and commercialization of INEX's proprietary oncology product, MARQIBO® (vincristine sulfate liposomes injection). After a ...
© 1997-2024 LUMITOS AG, All rights reserved